Clinical and Psychiatric Changes in Epileptic Patients with COVID-19 Infection
DOI:
https://doi.org/10.61788/njn.v1i23.05Keywords:
COVID infection, epilepsy, asthenia, post-COVID syndromeAbstract
The article provides information about clinical and mental changes in epileptic patients who have experienced COVID-19 infection. The frequency of these symptoms, their clinical characteristics and the dependence of their manifestation on the infection of COVID-19 were investigated. Various scales or questionnaires were used in the research. Observations have shown that epileptic seizures on the NHS-3 scale occur more frequently and tend to increase in severity in epileptic patients who have had an infection with COVID-19. When assessing the mental sphere of their patients (with the MMSE and HADS scales), it was found that cases of mental spectrum disorders prevail in epileptic patients who have experienced COVID-19. The presence of mild depression (BDI scale) and severe asthenia (MFI scale) were also more marked in this group. Analysis of the results showed that epileptic patients who had experienced a COVID-19 infection were more likely to have impaired cognitive function. Sleep disturbances were assessed using the MOS-SS scale, and it was found that epileptic patients with coronovirus infection were more likely to have moderate sleep disturbances than those without COVID-19. During the correlation analysis, it was determined that there is a direct positive relationship between the severity and frequency of epileptic seizures with the infection of COVID-19. All this shows the negative effect of the infection of COVID-19 on the course of epilepsy.
References
Tufan A., Güler A., Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs // Turk J Med Sci. 2020; 50 (SI-1): 620-632. https://doi.org/ 10.3906/sag2004-168.
Mao L., Wang M., Chen S., et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study // JAMA Neurol. 2020; 77 (6): 683-690. https://doi.org/10.1001/jamaneurol.2020.1127.
Chen W., Toprani S., Werbaneth K., Falco-Walter J. Status epilepticus and other EEG findings in patients with COVID-19: a case series // Seizure. 2020; 81: 198-200. https://doi.org/10.1016/j.seizure.2020.08.022.
Alkhotani A., Siddiqui M.I., Almuntashri F., Baothman R. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy // Epilepsy Behav. 2020; 112: 107323. https://doi.org/10.1016/j.yebeh.2020.107323.
Карлов В.А., Бурд С.Г., Лебедева А.В. и др. Эпилепсия и COVID-19. Тактика и лечение. Рекомендации Российской Противоэпилептической Лиги // Эпилепсия и пароксизмальные состояния. 2020; 12 (1): 84-8. https://doi.org/10.17749/2077-8333.2020.12.1.84-88.
Salaria M., Etemadifarb M., Gharagozlic K., et al. Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic // Epilepsy Behav. 2020; 112: 107442. https://doi.org/10.1016/j.yebeh.2020.107442.
Hao X., Zhou D., Li Z., et al. Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China // Epilepsia. 2020; 61 (6): 1166-1173. https://doi.org/10.1111/epi.16544.
Aji B.M., Larner A.J. Cognitive assessment of patients with epilepsy in the COVID-19 era // Prog Neurol Psychiatry. 2021; 25 (1): 23-25. https://doi.org/10.1002/pnp.694.
Карлов В.А., Иноземцева О.С., Новоселова Г.Б. К проблеме расстройства сна при эпилепсии // Эпилепсия и пароксизмальные состояния. 2017; 9 (1): 36-39. https://doi.org/10.17749/2077-8333.2017.9.1.036-039.
O'Donoghue M.F., Duncun J.S., Sander J.W. The national hospital seizure severity scale: a further development of the Chalfont Seizure Severity Scale // Epilepsia. 1996; 37 (6): 563-571. https://doi.org/10.1111/j.1528-1157.1996.tb00610.x.
Folstein M., Folstein S., McHugh P. Minimental state // J Psychiatr Res. 1975; 12 (3): 189-198. https://doi.org/10.1016/0022-3956(75)90026-6.
Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale // Acta Psychiatr Scand. 1983; 67 (6): 361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.
Beck A.T., Ward C.H., Mendelson M., et al. An inventory for measuring depression // Arch Gen Psychiatry. 1961; 4: 561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004.
Hays R.D., Martin S.A., Sesti A.M., Spritzer K.L. Psychometric properties of the Medical Outcomes Study Sleep measure // Sleep Med. 2005; 6 (1): 41-44. https://doi.org/10.1016/j.sleep.2004.07.006.
Smets E.M., Garssen B., Bonke B., De Haes J.C. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue // J Psychosom Res. 1995; 39(3): 315-325. https://doi.org/10.1016/0022-3999(94)00125-o.
Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020; 395 (10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
